HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kelley, D. E. Articles by Goodpaster, B. Search for Related Content PubMed PubMed Citation Articles by Kelley, D. E. Articles by Goodpaster, B.

Determination of the Lumped Constant for [¹⁸F]Fluorodeoxyglucose in Human Skeletal Muscle

Departments of Medicine and Radiology, University of Pittsburgh, Pittsburgh
Medical Research Service, Pittsburgh Veterans Affairs Medical Center, Pittsburgh, Pennsylvania

Correspondence: For correspondence or reprints contact: David E. Kelley, MD, University of Pittsburgh School of Medicine, Division of Endocrinology and Metabolism, E-1140 Biomedicai Science Tower. Pittsburgh, PA 15261.

ABSTRACT

Quantitative [¹⁸F]fluorodeoxyglucose (FDG) PET has considerable potential for the study of the physiology of skeletal muscle glucose metabolism and for the assessment of perturbations associated with insulin resistance in skeletal muscle. This application of FDG PET imaging depends in part on the determination of the analog effects of FDG relative to true glucose with respect to skeletal muscle. Deoxyglucose has a higher affinity for transporters than glucose and a lower affinity for hexokinase. This study was undertaken to assess the lumped constant (LC) for skeletal muscle, determined empirically as the quotient of FDG metabolism to that of [³H]glucose ([³H]G), and to assess whether the LC is affected by insulin, which is the principal hormonal regulator of glucose metabolism in muscle. Methods: Seventeen healthy lean volunteers were randomly assigned and were studied at insulin infusion rates of 0, 20, 40 and 120 mU/min/m² body surface area. After attaining steady-state euglycemic conditions, injections of FDG and [³H]G were given, and the fractional extraction (E) for each compound across the leg was measured by arterial and venous sampling for 90 min. The LC was calculated as the ratio of the respective fractional extractions (LC = E_FDG/E_[³H]G). Results: During fasting conditions (i.e., absence of insulin infusion), the LC for skeletal muscle was slightly greater than 1. Insulin had a robust effect to increase fractional extractions of both FDG and [³H]G. The effect was symmetrical for the two compounds, and, hence, the LC did not change significantly in response to progressive insulin stimulation. The mean value of the LC across insulin doses for human skeletal muscle was 1.23 ± 0.05. Conclusion: Direct comparison of [³H]G and FDG metabolism during insulin-stimulated conditions, across the in vivo tissue bed of skeletal muscle in the leg with both tracers given in an identical manner, yielded an LC value of 1.2, indicating that there was modest preferential uptake of FDG and that insulin did not alter the LC in skeletal muscle.

Key Words: lumped constant • insulin sensitivity • skeletal muscle • PET • deoxyglucose • [¹⁸F]fluorodeoxyglucose

This article has been cited by other articles:

				H. M. Sondergaard, M. Bottcher, M. Marie Madsen, O. Schmitz, S. B. Hansen, T. T. Nielsen, and H. E. Botker Impact of Type 2 Diabetes on Myocardial Insulin Sensitivity to Glucose Uptake and Perfusion in Patients with Coronary Artery Disease J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4854 - 4861. [Abstract] [Full Text] [PDF]

				A. Bertoldo, R. R. Pencek, K. Azuma, J. C. Price, C. Kelley, C. Cobelli, and D. E. Kelley Interactions Between Delivery, Transport, and Phosphorylation of Glucose in Governing Uptake Into Human Skeletal Muscle Diabetes, November 1, 2006; 55(11): 3028 - 3037. [Abstract] [Full Text] [PDF]

				P. Iozzo, A. Gastaldelli, M. J. Jarvisalo, J. Kiss, R. Borra, E. Buzzigoli, A. Viljanen, G. Naum, T. Viljanen, V. Oikonen, et al. 18F-FDG Assessment of Glucose Disposal and Production Rates During Fasting and Insulin Stimulation: A Validation Study J. Nucl. Med., June 1, 2006; 47(6): 1016 - 1022. [Abstract] [Full Text] [PDF]

				P. T. Fueger, D. P. Bracy, C. M. Malabanan, R. R. Pencek, D. K. Granner, and D. H. Wasserman Hexokinase II Overexpression Improves Exercise-Stimulated But Not Insulin-Stimulated Muscle Glucose Uptake in High-Fat-Fed C57BL/6J Mice Diabetes, February 1, 2004; 53(2): 306 - 314. [Abstract] [Full Text]

				K. Hallsten, K. A. Virtanen, F. Lonnqvist, H. Sipila, A. Oksanen, T. Viljanen, T. Ronnemaa, J. Viikari, J. Knuuti, and P. Nuutila Rosiglitazone but Not Metformin Enhances Insulin- and Exercise-Stimulated Skeletal Muscle Glucose Uptake in Patients With Newly Diagnosed Type 2 Diabetes Diabetes, December 1, 2002; 51(12): 3479 - 3485. [Abstract] [Full Text] [PDF]

				P. Iozzo, P. Chareonthaitawee, D. Dutka, D. J. Betteridge, E. Ferrannini, and P. G. Camici Independent Association of Type 2 Diabetes and Coronary Artery Disease With Myocardial Insulin Resistance Diabetes, October 1, 2002; 51(10): 3020 - 3024. [Abstract] [Full Text] [PDF]

				K. A. Virtanen, P. Lonnroth, R. Parkkola, P. Peltoniemi, M. Asola, T. Viljanen, T. Tolvanen, J. Knuuti, T. Ronnemaa, R. Huupponen, et al. Glucose Uptake and Perfusion in Subcutaneous and Visceral Adipose Tissue during Insulin Stimulation in Nonobese and Obese Humans J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3902 - 3910. [Abstract] [Full Text] [PDF]

				D. E. Kelley, K. V. Williams, J. C. Price, T. M. McKolanis, B. H. Goodpaster, and F. L. Thaete Plasma Fatty Acids, Adiposity, and Variance of Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5412 - 5419. [Abstract] [Full Text] [PDF]

				P. Peltoniemi, H. Yki-Jarvinen, H. Laine, V. Oikonen, T. Ronnemaa, K. Kalliokoski, O. Raitakari, M. J. Knuuti, and P. Nuutila Evidence for Spatial Heterogeneity in Insulin- and Exercise-Induced Increases in Glucose Uptake: Studies in Normal Subjects and Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5525 - 5533. [Abstract] [Full Text] [PDF]

				A. Bertoldo, P. Peltoniemi, V. Oikonen, J. Knuuti, P. Nuutila, and C. Cobelli Kinetic modeling of [18F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E524 - E536. [Abstract] [Full Text] [PDF]

				K. V. Williams, J. C. Price, and D. E. Kelley Interactions of Impaired Glucose Transport and Phosphorylation in Skeletal Muscle Insulin Resistance: A Dose-Response Assessment Using Positron Emission Tomography Diabetes, September 1, 2001; 50(9): 2069 - 2079. [Abstract] [Full Text] [PDF]

				P. Peltoniemi, H. Yki-Järvinen, V. Oikonen, A. Oksanen, T. O. Takala, T. Rönnemaa, M. Erkinjuntti, M. J. Knuuti, and P. Nuutila Resistance to Exercise-Induced Increase in Glucose Uptake During Hyperinsulinemia in Insulin-Resistant Skeletal Muscle of Patients With Type 1 Diabetes Diabetes, June 1, 2001; 50(6): 1371 - 1377. [Abstract] [Full Text]

				P. Peltoniemi, P. Lonnroth, H. Laine, V. Oikonen, T. Tolvanen, T. Gronroos, L. Strindberg, J. Knuuti, and P. Nuutila Lumped constant for [18F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1122 - E1130. [Abstract] [Full Text] [PDF]